Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05256992 · ClinicalTrials.gov registry record · NA
TYRO Champion Dads Project Study
A NA study, sponsored by Midwest Evaluation & Research.
- Completed
- Registry status
- NA
- Development phase
- 748
- Enrollment target
NCT05256992: Completed NA study, sponsored by Midwest Evaluation & Research.
NCT05256992 is a NA study that has completed, run by Midwest Evaluation & Research. The registered enrollment target is 748 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05256992, a NA study, has completed, sponsored by Midwest Evaluation & Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 748 participants
- Enrollment target
Study Summary
This impact evaluation aims to determine if the addition of 10 hours of domestic violence prevention programming is effective at improving outcomes among those program participants who are randomly assigned to the treatment group. Both study groups will receive standard TYRO Champion Dads services (the TYRO Dads and TYRO Core Communication evidence-based curricula, plus support services), but only the treatment group will be offered the additional Ray of Hope curriculum hours focused on mitigating risk factors related to domestic violence.
Primary Outcome
What is the impact of enhanced TCD services (treatment) compared to standard TCD services only (control) on healthy parent behavior 6 months after TCD enrollment? * Average of 11 survey items that relate to frequency of positive interactions with participant's youngest child using categories on a five-point scale where 1 is never and 5 is every day or almost every day * Higher scores are always positive The 11 items are measured as a construct. All items are added together and divided by 11 to
Interventions
- OTHER Standard Servies + Ray of Hope Curriculum
- OTHER Standard Services
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 748 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2025-08-29 |
| Phase | NA |
What the finished NCT05256992 record still lists
NCT05256992 is an interventional study that assigns participants to a tested intervention. The registered 748 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Servies + Ray of Hope Curriculum is the first listed.
NCT05256992 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05256992 about?
NCT05256992 is a clinical study titled "TYRO Champion Dads Project Study". This impact evaluation aims to determine if the addition of 10 hours of domestic violence prevention programming is effective at improving outcomes among those program participants who are randomly assigned to the treatment group. Both study groups will receive standard TYRO Champion Dads services (...
What is the current status of trial NCT05256992?
This trial is currently completed. It is a NA study. The enrollment target is 748 participants. The study started on 2021-04-01. Estimated completion is 2025-08-29.
What interventions are being tested in trial NCT05256992?
The interventions under investigation include: Standard Servies + Ray of Hope Curriculum (OTHER), Standard Services (OTHER).
Who is sponsoring clinical trial NCT05256992?
This trial is sponsored by Midwest Evaluation & Research, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05256992's enrollment target sits among peer trials
748 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI